Abbvie Contract MFG

Proprietary Hot Melt Extrusion (HME) technology has become a cornerstone in drug manufacturing, revolutionizing the formulation and production of pharmaceutical products. This advanced process combines heat and pressure to transform raw components into a homogeneous, uniform product. The unique aspect of proprietary HME lies in its diverse formulations and techniques, which are often closely guarded by pharmaceutical companies to maintain a competitive advantage. One of the standout features of proprietary HME is its flexibility. The process can integrate a wide range of poorly soluble drugs and various pharmaceutical ingredients into a single dosage form. This versatility addresses formulation challenges that traditional methods may struggle with, ultimately enhancing drug bioavailability and efficacy. Moreover, HME’s adaptability allows for the development of customized formulations tailored to specific patient needs, fostering innovation and differentiation in the pharmaceutical ma...

Hot melt extrusion is an advanced and increasingly important manufacturing technique in the pharmaceutical industry. Originally used in industries like plastics and food processing, HME has been adapted for pharmaceutical applications to address challenges in drug solubility, stability, and controlled release. It has become a valuable tool for creating complex drug delivery systems and improving the bioavailability of poorly soluble active pharmaceutical ingredients (APIs). How Hot Melt Extrusion Works Hot melt extrusion involves the mixing, heating, and pushing of drug materials and polymers through a heated barrel and screw system. The process applies heat and pressure to melt and blend the materials into a homogenous mixture, which is then extruded through a die to form various shapes like granules, pellets, or films. Once extruded, the material is cooled and solidified into the desired final product. Because HME involves a continuous, solvent-free process, it offers significa...